This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Merck Sharp + Dohme Corp.. Active years: 2013.
Company Filing History:
Years Active: 2013
Title: Christopher Stanley Pridgen: Innovator in Pharmaceutical Formulations
Introduction
Christopher Stanley Pridgen is a notable inventor based in Union City, NJ (US). He has made significant contributions to the field of pharmaceutical formulations, particularly through his innovative methods for isolating specific chemical compounds. His work has implications for the development of new medications and treatments.
Latest Patents
Pridgen holds a patent for a process titled "Process for the precipitation and isolation of 6,6-dimethyl-3-aza-bicyclo [3.1.0] hexane-amide compounds by controlled precipitation and pharmaceutical formulations containing same." This invention provides a method for the continuous precipitation and isolation of an amorphous solid particulate form of a specific compound, which has controlled physical properties. The patent also includes pharmaceutical formulations that comprise the precipitated compound, showcasing its potential applications in medicine.
Career Highlights
Pridgen is associated with Merck Sharp & Dohme Corp., a leading global healthcare company. His work at Merck has allowed him to focus on innovative solutions in drug formulation and development. His patent reflects his commitment to advancing pharmaceutical science and improving patient outcomes.
Collaborations
Throughout his career, Pridgen has collaborated with esteemed colleagues, including Wing-Kee Philip Cho and Dimitrios Zarkadas. These collaborations have likely contributed to the depth and breadth of his research and innovations.
Conclusion
Christopher Stanley Pridgen is a distinguished inventor whose work in pharmaceutical formulations has the potential to impact the healthcare industry significantly. His innovative methods and dedication to research exemplify the spirit of invention in the field of pharmaceuticals.